Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally E Carty

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
<i>THADA</i> fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancerFederica Panebianco, Lindsey M Kelly, Pengyuan Liu, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2023
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized ManagementSimion Chiosea, Steven P Hodak, Linwah Yip, et al.
JAMA Oncology|November 13, 2018
Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter StudyDavid L Steward, Sally E Carty, Rebecca S Sippel, et al.
Surgery|November 12, 2013
A multi-institutional international study of risk factors for hematoma after thyroidectomyMichael J Campbell, Kelly L McCoy, Wen T Shen, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
<i>THADA</i> fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancerFederica Panebianco, Lindsey M Kelly, Pengyuan Liu, et al.
The Journal of Clinical Endocrinology and Metabolism|April 18, 2023
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized ManagementSimion Chiosea, Steven P Hodak, Linwah Yip, et al.
JAMA Oncology|November 13, 2018
Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter StudyDavid L Steward, Sally E Carty, Rebecca S Sippel, et al.
Surgery|November 12, 2013
A multi-institutional international study of risk factors for hematoma after thyroidectomyMichael J Campbell, Kelly L McCoy, Wen T Shen, et al.
Pageof 15